Literature DB >> 533298

Maturation of caffeine elimination in infancy.

J V Aranda, J M Collinge, R Zinman, G Watters.   

Abstract

The developmental changes in caffeine elimination were studied in 7 infants aged between 2 1/2 weeks and 6 months. Adult plasma clearance rate of caffeine was achieved at 3 to 4 1/2 months of age. Plasma half-life and elimination rate reached adult levels after 3 to 4 1/2 months and seemed to exceed adult capacity thereafter. No significant changes in apparent volume of distribution were noted. Our data provide some indication of the age in infancy when the low rates of caffeine elimination in the neonate increase to the adult rate.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 533298      PMCID： PMC1545746          DOI： 10.1136/adc.54.12.946

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  23 in total

1.  A study of the metabolism of theobromine, theophylline, and caffeine in man.

Authors:  H H CORNISH; A A CHRISTMAN
Journal:  J Biol Chem       Date:  1957-09       Impact factor: 5.157

Review 2.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

3.  Effect of Aroclor 1254, phenobarbital, and polycyclic aromatic hydrocarbons on the plasma clearance of caffeine in the rat.

Authors:  R M Welch; S Y Hsu; R L DeAngelis
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

4.  Efficacy of caffeine in treatment of apnea in the low-birth-weight infant.

Authors:  J V Aranda; W Gorman; H Bergsteinsson; T Gunn
Journal:  J Pediatr       Date:  1977-03       Impact factor: 4.406

Review 5.  Clinical pharmacokinetics of digoxin in infants.

Authors:  G Wettrell; K E Andersson
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

6.  Phenobarbital and diphenylhydantoin levels in neonates with seizures.

Authors:  M J Painter; C Pippenger; H MacDonald; W Pitlick
Journal:  J Pediatr       Date:  1978-02       Impact factor: 4.406

7.  Effect of smoking on caffeine clearance.

Authors:  W D Parsons; A H Neims
Journal:  Clin Pharmacol Ther       Date:  1978-07       Impact factor: 6.875

8.  Metabolism of theophylline to caffeine in premature newborn infants.

Authors:  C Bory; P Baltassat; M Porthault; M Bethenod; A Frederich; J V Aranda
Journal:  J Pediatr       Date:  1979-06       Impact factor: 4.406

9.  Caffeine metabolism in the newborn.

Authors:  A Aldridge; J V Aranda; A H Neims
Journal:  Clin Pharmacol Ther       Date:  1979-04       Impact factor: 6.875

10.  Pharmacokinetic profile of caffeine in the premature newborn infant with apnea.

Authors:  J V Aranda; C E Cook; W Gorman; J M Collinge; P M Loughnan; E W Outerbridge; A Aldridge; A H Neims
Journal:  J Pediatr       Date:  1979-04       Impact factor: 4.406
View more
  26 in total

Review 1.  Neonatal exposure to drugs in breast milk.

Authors:  Patrick J McNamara; Maggie Abbassi
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

2.  Does nausea and vomiting of pregnancy play a role in the association found between maternal caffeine intake and fetal growth restriction?

Authors:  S M Boylan; D C Greenwood; N Alwan; M S Cooke; V A Dolby; A W M Hay; S F L Kirk; J C Konje; N Potdar; S Shires; N A B Simpson; N Taub; J D Thomas; J J Walker; K L M White; C P Wild; J E Cade
Journal:  Matern Child Health J       Date:  2013-05

3.  Adolescent caffeine consumption increases adulthood anxiety-related behavior and modifies neuroendocrine signaling.

Authors:  Casey E O'Neill; Ryan J Newsom; Jacob Stafford; Talia Scott; Solana Archuleta; Sophia C Levis; Robert L Spencer; Serge Campeau; Ryan K Bachtell
Journal:  Psychoneuroendocrinology       Date:  2016-02-01       Impact factor: 4.905

4.  Sequential updating of a new dynamic pharmacokinetic model for caffeine in premature neonates.

Authors:  Sandrine Micallef; Billy Amzal; Véronique Bach; Karen Chardon; Pierre Tourneux; Frédéric Y Bois
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 5.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

Review 6.  Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.

Authors:  Katherine Schoen; Tian Yu; Chris Stockmann; Michael G Spigarelli; Catherine M T Sherwin
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.022

7.  Human retinal endothelial cells and astrocytes cultured on 3-D scaffolds for ocular drug discovery and development.

Authors:  Kay D Beharry; Charles L Cai; Gloria B Valencia; Douglas Lazzaro; Arwin M Valencia; Fabrizio Salomone; Jacob V Aranda
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-09-18       Impact factor: 3.072

8.  Serum caffeine concentrations and short-term outcomes in premature infants of ⩽29 weeks of gestation.

Authors:  P Alur; V Bollampalli; T Bell; N Hussain; J Liss
Journal:  J Perinatol       Date:  2014-12-18       Impact factor: 2.521

9.  Effects of adolescent caffeine consumption on cocaine self-administration and reinstatement of cocaine seeking.

Authors:  Tracey A Larson; Casey E O'Neill; Michaela P Palumbo; Ryan K Bachtell
Journal:  J Psychopharmacol       Date:  2018-11-28       Impact factor: 4.153

10.  Pharmacokinetic aspects of caffeine in premature infants with apnoea.

Authors:  R Gorodischer; M Karplus
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.